programmed death-ligand 1

E238185

Programmed death-ligand 1 (PD-L1) is an immune checkpoint protein expressed on various cells that suppresses T-cell activity by engaging PD-1, enabling tumors to evade immune surveillance.

All labels observed (5)

Label Occurrences
CD274 1
CD274 gene 1
PD-L1 1

How this entity was disambiguated

Statements (60)

Predicate Object
instanceOf cell surface glycoprotein
immune checkpoint ligand
protein
associatedWithDisease Hodgkin lymphoma
gastric cancer
head and neck squamous cell carcinoma
hepatocellular carcinoma
melanoma
non-small cell lung cancer
renal cell carcinoma
triple-negative breast cancer
urothelial carcinoma
belongsToFamily B7 family
bindsTo PD-1
programmed cell death protein 1
biologicalProcess immune checkpoint signaling
inhibition of cytotoxic T lymphocyte function
negative regulation of T cell activation
peripheral T cell tolerance
tumor immune evasion
cellularLocation cell surface
plasma membrane
encodedByGene programmed death-ligand 1 self-linksurface differs
surface form: CD274 gene
expressedOn B cells
T cells
antigen-presenting cells
dendritic cells
endothelial cells
epithelial cells
macrophages
tumor cells
geneOntologyTerm GO:0031294
hasDomain cytoplasmic tail
extracellular IgC-like domain
extracellular IgV-like domain
transmembrane domain
hasPostTranslationalModification N-linked glycosylation
hasSynonym B7-H1
programmed death-ligand 1 self-linksurface differs
surface form: CD274

programmed death-ligand 1 self-linksurface differs
surface form: PD-L1

programmed death-ligand 1 self-linksurface differs
surface form: PDCD1 ligand 1
inhibits T cell cytokine production
T cell cytotoxicity
T cell proliferation
locatedOnChromosome human chromosome 9p24.1
measuredBy immunohistochemistry
molecularFunction inhibitory immune receptor ligand
organism Homo sapiens
pathway PD-1 signaling pathway
regulates immune tolerance to self-antigens
targetOfDrug atezolizumab
avelumab
Imfinzi
surface form: durvalumab

nivolumab
Keytruda
surface form: pembrolizumab
uniprotId Q9NZQ7
upregulatedBy inflammatory cytokines
interferon-gamma
usedAsBiomarkerFor response to PD-1 blockade therapy
response to PD-L1 blockade therapy

How these facts were elicited

Referenced by (5)

Full triples — surface form annotated when it differs from this entity's canonical label.

Tecentriq bindsTo programmed death-ligand 1
programmed death-ligand 1 hasSynonym programmed death-ligand 1 self-linksurface differs
this entity surface form: PD-L1
programmed death-ligand 1 hasSynonym programmed death-ligand 1 self-linksurface differs
this entity surface form: CD274
programmed death-ligand 1 hasSynonym programmed death-ligand 1 self-linksurface differs
this entity surface form: PDCD1 ligand 1
programmed death-ligand 1 encodedByGene programmed death-ligand 1 self-linksurface differs
this entity surface form: CD274 gene